
July 7 (Reuters) – The weight-loss drug market is booming, with biotech firms racing to capture a slice of a fast-growing sector dominated by Novo Nordisk and Eli Lilly. Analysts expect the
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
US 30-year mortgage rate hits highest in nearly three years
By Ann Saphir Oct 7 (Reuters) - The interest rate on the most common US home…
CAS to hear Senegal appeal over stripped African Cup of Nations title
VIDEO SHOWS: ARCHIVE OF COURT OF ARBITRATION FOR SPORT (CAS) HQ AND CAS SECRETARY GENERAL,…
UPDATE 1-South Korea denies Ukrainian report that it eased Russia's fuel crisis
(Adds background in paragraph 3, more comments from South Korea in paragraph 4-5) SEOUL, Oct…